Efficacy of a commercial probiotic in protecting mice against 

Salmonella infection by Cheng, Joo Chin et al.
103
5th Proceedings of the Seminar in Veterinary Sciences, 5 - 8 January 2010
Efficacy of a Commercial Probiotic in Protecting Mice against 
Salmonella Infection
Cheng Joo Chin, 1Abdul Rani Bahaman & 1Zunita Zakaria
Department of Veterinary Pathology and Microbiology
Faculty of Veterinary Medicine, Universiti Putra Malaysia
Abstract
It is believed that probiotics are able to inhibit pathogenic bacteria from colonizing 
the gastrointestinal tract and thereby prevent infection and even mortality. On this 
basis, this project was undertaken to examine the efficacy of a commercial probiotic 
in preventing infection in the mouse model. This probiotic is made up of 8 bacterial 
species from 3 genera. Forty 6-week old white ICR mice were used in this project. 
The mice were divided into 7 groups consisting of positive and negative controls, 2 
preventive groups and 3 treatment groups. The infective inocula were made up of a 
Salmonella typhimurium isolate. All mice in the positive control and treatment groups 
were severely affected when inoculated with the Salmonella isolate. Eleven (73%) of 
the 15 mice in the treatment groups died from the Salmonella infection. Salmonella 
was recovered from the internal organs of the mice in the positive control group and 
the treatment groups. No Salmonella was isolated from the internal organs of the 
mice in the negative control and the preventive groups. This showed that the probiotic 
was not able to prevent serious infection if given during or after infection. When the 
probiotic was given earlier as a prophylaxis, it was able to prevent serious infection. 
In this project, it is seen that none of the mice from the preventive groups succumbed 
to the Salmonella infection. It was clearly shown that probiotics were able to prevent 
adverse infection if given earlier as a prophylaxis.
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